Claude fails to create scorpion antivenom in experiment

Investment research firm Citrini Research teamed up with Anthropic to test whether an unreleased Claude version could develop scorpion antivenom from scratch. It produced promising starting points but nothing close to a drug, experts said, underscoring hype around AI drug discovery.

• Claude designs protein binders against scorpion neurotoxins; 17 of 211 designs meet criteria2026-10-20
• Experts question Anthropic report on AI reshaping work2026-10-23
• Anthropic's Claude writes and proves code safe automatically2026-10-23
• Google Cloud launches Anthropic-managed Claude option2026-10-22
• HHS Plans Sole-Source Anthropic Claude Contract2026-10-21